Deb­o­rah Birx en­ters new phase as biotech CEO; Ve­rastem chief an­nounces his re­tire­ment

→ Af­ter en­ter­ing the pub­lic con­scious­ness with the White House Coro­n­avirus Task Force and em­bark­ing on a sub­se­quent book tour, Deb­o­rah Birx has re­placed Bri­an Var­num as CEO of Ar­ma­ta Phar­ma­ceu­ti­cals, a Cal­i­for­nia biotech de­vel­op­ing bac­te­rio­phages. Con­cur­rent with Birx’s ap­point­ment, Ar­ma­ta al­so picked up $25 mil­lion in fund­ing through a sub­sidiary of In­no­vi­va, where Birx had a seat on the board of di­rec­tors be­fore join­ing Ar­ma­ta. Birx was a main­stay with then-NI­AID Di­rec­tor An­tho­ny Fau­ci in White House press brief­in­gs at the height of the Covid-19 pan­dem­ic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Senior Associate

Alexandria Real Estate Equities

Durham, NC, USA